Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial-Reference-Cited by-同舟云学术

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

Published:2016 Issue:6 Volume:92 Page:362-370
ISSN:0025-7931
Container-title:Respiration
language:en
Short-container-title:Respiration

Author:

Grünig Ekkehard,Benjamin Nicola,Lange Tobias J.,Krueger Ulrich,Klose Hans,Neurohr Claus,Wilkens Heinrike,Halank Michael,Seyfarth Hans-Jürgen,Held Matthias,Traube Andrew,Pernow Michelle,Grover E. Robert,Egenlauf Benjamin,Gerhardt Felix,Viethen Thomas,Rosenkranz Stephan

Publisher

S. Karger AG

Subject

Pulmonary and Respiratory Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil;Respiratory Medicine;2023-11

2. Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil;Pulmonary Circulation;2023-07

3. Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension;Respiration;2023

4. Caractéristiques des patients traités par prostanoïdes pour une hypertension artérielle pulmonaire associée à une connectivite : étude multicentrique rétrospective;La Revue de Médecine Interne;2021-12

5. Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension;Pulmonary Circulation;2021-09